Loading
LL
Lexston Life Sciences Corp. Stock: price and insider trades · Canada
Lexston Life Sciences Corp.: what insiders have been doing
Lexston Life Sciences Corp. is a listed company. Its insiders report their share dealings to SEDI. The past year has been quiet: not a single insider filing for Lexston Life Sciences Corp. The previous disclosure was published on 2 March 2023.
Since 2021, the database holds 13 purchases and 6 sales by insiders of the company.
Source: insider filings from SEDI. Past trades are no guide to future returns.
Insider Decl.
29
Thresholds
n/a
Buy Volume
€40,078
13 ops. · all time
Sell Volume
€888,096
6 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 2 March 2023
Declarations29 total
Common SharesTSXSEDI:4086470
74,000 shares@ CA$0.07528.0% of flowCommon SharesTSXSEDI:4064014
Canonical exit: 17 Apr 2023 (T+90)
29,000 shares@ CA$0.077.2% of flowCommon SharesTSXSEDI:4063950
Canonical exit: 13 Apr 2023 (T+90)
100,000 shares@ CA$0.07526.6% of flowCommon SharesTSXSEDI:4063952
Canonical exit: 16 Apr 2023 (T+90)
106,000 shares@ CA$0.07528.2% of flowCommon SharesTSXSEDI:4063953
Canonical exit: 17 Apr 2023 (T+90)
40,000 shares@ CA$0.06513.1% of flowCommon SharesTSXSEDI:4064011
Canonical exit: 16 Apr 2023 (T+90)
33,000 shares@ CA$0.06510.8% of flowCommon SharesTSXSEDI:4063118
Canonical exit: 13 Apr 2023 (T+90)
175,000 shares@ CA$0.06138.0% of flowCommon SharesTSXSEDI:4062519
Canonical exit: 12 Apr 2023 (T+90)
100,000 shares@ CA$0.05Common SharesTSXSEDI:4051834
Canonical exit: 30 Mar 2023 (T+90)
Common SharesTSXSEDI:4001911
Common SharesTSXSEDI:4001913
5,040,800 sharesCommon SharesTSXSEDI:3962034
1,000 shares@ CA$0.100.5% of flowCommon SharesTSXSEDI:3875597
Canonical exit: 21 Apr 2022 (T+90)
50,000 shares@ CA$0.10100.0% of flowCommon SharesTSXSEDI:3872856
Canonical exit: 20 Apr 2022 (T+90)
60,500 shares@ CA$0.11235.0% of flowCommon SharesTSXSEDI:3871958
Canonical exit: 19 Apr 2022 (T+90)
44,000 shares@ CA$17.0059.6% of flowCommon SharesTSXSEDI:3869413
30,000 shares@ CA$17.0040.4% of flowCommon SharesTSXSEDI:3869412
7,500 shares@ CA$0.1545.5% of flowCommon SharesTSXSEDI:3839064
Canonical exit: 28 Feb 2022 (T+90)
10,000 shares@ CA$0.13554.5% of flowCommon SharesTSXSEDI:3828012
Canonical exit: 7 Feb 2022 (T+90)
59,625 shares@ CA$0.17549.7% of flowCommon SharesTSXSEDI:3804935
14,250 shares@ CA$0.17512.1% of flowCommon SharesTSXSEDI:3790430
50,000 shares@ CA$0.1536.5% of flowCommon SharesTSXSEDI:3790426
2,000 shares@ CA$0.171.7% of flowCommon SharesTSXSEDI:3790427
Common SharesTSXSEDI:3764991
Common SharesTSXSEDI:3764929
25 of 29 declarations
About Lexston Life Sciences Corp.
Lexston Life Sciences Corp. is a company listed on the Toronto Stock Exchange, specializing in the life sciences sector. It focuses on developing innovative solutions to enhance human health.
